Giuseppe Pantaleo
Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial.
Manuel O, Laager M, Hirzel C, Neofytos D, Walti L, Hönger G, Binet F, Schnyder A, Stampf S, Koller M, Mombelli M, Kim M, Hoffmann M, Koenig K, Hess C, Burgener A, Cippà P, Hübel K, Müller T, Sidler D, Dahdal S, Suter-Riniker F, Villard J, Zbinden A, Pantaleo G, Semmo N, Hadaya K, Enriquez N, Meylan P, Froissart M, Golshayan D, Fehr T, Huynh-Do U, Pascual M, Van Delden C, Hirsch H, Jüni P, Müller N, Swiss Transplant Cohort Study (STCS). Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial. Clin Infect Dis 2023
22.09.2023Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial.
22.09.2023Clin Infect Dis 2023
Manuel Oriol, Laager Mirjam, Hirzel Cédric, Neofytos Dionysios, Walti Laura N, Hönger Gideon, Binet Françoise-Isabelle, Schnyder Aurelia, Stampf Susanne, Koller Michael, Mombelli Matteo, Kim Min Jeong, Hoffmann Matthias, Koenig Katrin, Hess Christoph, Burgener Anne-Valérie, Cippà Pietro E, Hübel Kerstin, Müller Thomas F, Sidler Daniel, Dahdal Suzan, Suter-Riniker Franziska, Villard Jean, Zbinden Andrea, Pantaleo Giuseppe, Semmo Nasser, Hadaya Karine, Enriquez Natalia, Meylan Pascal R, Froissart Marc, Golshayan Délaviz, Fehr Thomas, Huynh-Do Uyen, Pascual Manuel, Van Delden Christian, Hirsch Hans H., Jüni Peter, Müller Nicolas J., Swiss Transplant Cohort Study (STCS)
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort.
Menges D, Zens K, Ballouz T, Caduff N, Llanas-Cornejo D, Aschmann H, Domenghino A, Pellaton C, Perreau M, Fenwick C, Pantaleo G, Kahlert C, Münz C, Puhan M, Fehr J. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort. Nat Commun 2022; 13:4855.
18.08.2022Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort.
18.08.2022Nat Commun 2022; 13:4855
Menges Dominik, Zens Kyra, Ballouz Tala, Caduff Nicole, Llanas-Cornejo Daniel, Aschmann Hélène E, Domenghino Anja, Pellaton Céline, Perreau Matthieu, Fenwick Craig, Pantaleo Giuseppe, Kahlert Christian, Münz Christian, Puhan Milo A, Fehr Jan S
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Ciuffreda D, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers J, Pantaleo G, Oneta C, Malinverni R, Comte D, Cavassini M, Giostra E, Buhler L, Perruchoud M, Heim M, Battegay M, Genné D, Mulhaupt B, Dutoit V. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. European journal of immunology 2008; 38:2665-77.
01.10.2008Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
01.10.2008European journal of immunology 2008; 38:2665-77
Ciuffreda Donatella, Bernasconi Enos, Monnat Martine, Cerny Andreas, Chuard Christian, Borovicka Jan, Mentha Gilles, Pascual Manuel, Gonvers Jean-Jacques, Pantaleo Giuseppe, Oneta Carl, Malinverni Raffaele, Comte Denis, Cavassini Matthias, Giostra Emiliano, Buhler Leo, Perruchoud Monika, Heim Markus H, Battegay Manuel, Genné Daniel, Mulhaupt Beat, Dutoit Valérie
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
Fellay J, Telenti A, Eap C, Vernazza P, Schinkel A, Ruiz L, Retelska D, Pantaleo G, Opravil M, Furrer H, Decosterd L, Chave J, Buclin T, Back D, Meaden E, Marzolini C, Swiss HIV Cohort Study. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002; 359:30-6.
05.01.2002Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
05.01.2002Lancet 2002; 359:30-6
Fellay Jacques, Telenti Amalio, Eap Chin B, Vernazza Pietro, Schinkel Alfred H, Ruiz Lidia, Retelska Dorota, Pantaleo Giuseppe, Opravil Milos, Furrer Hansjakob, Decosterd Laurent A, Chave Jean Philippe, Buclin Thierry, Back David J, Meaden Emma R, Marzolini Catia, Swiss HIV Cohort Study